Society
Human cloning offers immortality, sort of.
Because of advances in biotechnology, only taxes are certain now.
Join Bioeconomy.XYZ’s new Slack Community to build better connections in the new hybrid world and to foster more discussion around the most pressing topics our writers and readers are surfacing.
Longevity is a blistering hot area of R&D these days, attracting billions of investment dollars — and for good reason. Getting old isn’t any fun. More and more things start to wear out or break down until we eventually die. Finito.
For the last few decades, we’ve been deciphering the molecular mechanisms of aging.
The field is exploding. The research results are tantalizing, particularly if you’re a mouse. But practical therapies for you and me are still years away. Biology is complicated and the drug development process is slow, expensive, and poorly suited for outcomes that can only be evaluated near the end of life.
I’m optimistic that my kids or grandkids will benefit from this work, but nearing my sixth decade I may be dust before I can get a prescription for anything FDA-approved that slows or stops the aging process. Or, better, reverses it.
